Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

854 studies match

clinicaltrialsPublishedShowing 501–550 of 854 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02538666	An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy(CheckMate 451)	completed	Phase 3	907	Bristol-Myers SquibbINDUSTRY	32	Jan 5, 2023	clinicaltrials
NCT01957176	A Rollover Study to Provide Continued Treatment With Eltrombopag	completed	Phase 4	22	Novartis PharmaceuticalsINDUSTRY